Scientists have identified blood-based biomarkers that can reliably distinguish inflammatory breast cancer (IBC) from other breast cancer subtypes, a finding published in Science Advances. The study used Thermostable Group II Intron Reverse Transcriptase (TGIRT) sequencing, a method developed by Alan Lambowitz’s team at The University of Texas at Austin. TGIRT uses a more robust enzyme that tolerates extreme conditions and captures complex, fragmented RNAs that standard methods often miss.
Clinical samples and medical insights were provided by Savitri Krishnamurthy at The University of Texas MD Anderson Cancer Center and Naoto Ueno, then a professor at the Morgan Welch Inflammatory Breast Cancer Program and Clinic at UT MD Anderson and now director of the University of Hawai’i Cancer Center. The researchers also developed analytic methods to focus on protein-coding genes specific to IBC tumors.
Key findings include higher levels of noncoding RNAs and increased white blood cell counts in IBC patient blood compared with healthy or non-IBC patients. In plasma, IBC samples contained many intron RNA fragments, while healthy plasma mostly carried mRNA fragments. This pattern points to immune activation and imbalances in RNA splicing that reduce mRNA production. Overall, the team proposed several potential blood-based biomarkers that could improve diagnosis, monitoring and the development of new therapies. The work was funded by the National Institutes of Health, The Welch Foundation, the Breast Cancer Research Foundation, the UT MD Anderson Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, and the State of Texas Rare and Aggressive Breast Cancer Research Program; a full list of authors and disclosures is available with the paper in Science Advances.
Difficult words
- biomarker — molecule in blood used to detect diseasebiomarkers
- reverse transcriptase — enzyme that makes DNA from RNA
- thermostable — able to work at high temperatures
- noncoding RNA — RNA molecules that do not code proteinsnoncoding RNAs
- intron — section of RNA removed during processing
- splicing — process that joins and removes RNA parts
- immune activation — stimulation of the body's immune response
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could blood-based biomarkers change diagnosis or monitoring for patients with inflammatory breast cancer?
- What advantages might thermostable enzymes like TGIRT offer for sequencing in clinical tests?
- What practical challenges could arise when turning these research findings into routine blood tests?
Related articles
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
AI is changing basic health care in sub‑Saharan Africa
Artificial intelligence is already helping basic medical care in parts of sub‑Saharan Africa. Pilot projects in Kenya, Ghana and Rwanda show faster diagnosis, fewer wrong prescriptions and quicker delivery of blood and imaging results.
Study finds Abbott-Bioline malaria test gives many false negatives
A study on the Thailand–Myanmar border found the Abbott-Bioline rapid malaria test missed many infections. Researchers call it “not fit for purpose”; WHO and the manufacturer are reviewing the test and further studies are under way.
Lower mGlu5 receptor found across autistic adult brains
A study in The American Journal of Psychiatry found lower availability of a glutamate receptor called mGlu5 across the brains of autistic adults. Researchers used PET, MRI and EEG and say the result could affect future diagnosis and treatment.